Multiple Sclerosis Clinical Trial 2014-002

[LCID Study Number: 2014-002]

A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfideraâ„¢ (Dimethyl Fumarate) When Used in Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM)

The purpose of this study is to gain a better understanding of the benefits and risks of long-term treatment with Tecfidera in patients with multiple sclerosis (MS).

Disease/Condition: Multiple Sclerosis

Department: Neurology

Status: Active, Not Recruiting

Location(s): Multiple Locations

Primary Contact Email: [email protected]

Protocol #: 2014-002
Principal Investigator(s): Jayashri Srinivasan
Study Coordinator(s): Melissa Dunbar
Trial Phase: Sponsor Initiated Study Observational